📰 Fim Phase News
Page 2 - Fim Phase News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Fim Phase. Real-time updates on events, politics, business and more.
February 22, 2023
ORYZON Hosting Key Opinion Leader Webinar on Targeting Lysine Specific Demethylase 1 (LSD1) in CNS and Psychiatric Disorders and Oncology
February 17, 2023
17.02.2023 - Strong clinical progress in both oncology and CNS Cash, cash equivalents and marketable securities totaled $22.7 million as of December 31, 2022 MADRID, Spain and BOSTON, Feb. 17, 2023 (GLOBE NEWSWIRE) - Oryzon Genomics, S.A. (ISIN ...
February 6, 2023
BIO CEO & Investor Conference 2023 IASLC 2023 Targeted Therapies of Lung Cancer Meeting 16th Annual European Life Sciences CEO ForumCancer Epigenetics Institute Symposium: From Genes to Chromatin... | February 6, 2023
January 18, 2023
Collaborative study with Fox Chase Cancer Center Trial will assess the safety and efficacy of iadademstat in pulmonary and extrapulmonary NECsPart of a...
January 18, 2023
18 January 2023 ORYZON announces First Patient In in NET, a collaborative Phase II basket study with iadademstat in R/R patients with neuroendocrine carcinomas ... | January 18, 2023
January 18, 2023
ORYZON announces First Patient In in NET, a collaborative Phase II basket study with iadademstat in R/R patients with neuroendocrine carcinomas
May 5, 2022
05.05.2022 - Oryzon invests $4.2 million in R&D in the first quarter 2022MADRID, Spain and CAMBRIDGE, Mass., May 05, 2022 (GLOBE NEWSWIRE) - Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics ...
April 29, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
January 3, 2022
40th Annual J.P. Morgan Healthcare ConferenceBiotech Showcase 202211th Annual LifeSci Partners Corporate Access Event 2022H.C. Wainwright Bioconnect ConferenceBioMed Event 2022 in Paris MADRID, Spain ...